• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Xetra	89,870	27.06.24 17:35:33	-1,060	-1,17%	0,000	0,000	90,140	90,930
	Regeneron Pharmaceuticals	881535	NASDAQ	1.050,570	27.06.24 21:41:53	-18,590	-1,74%	1.049,320	1.051,600	1.071,220	1.069,160